IBRX — IMMUNITYBIO INC

Ownership history in Alpine Global Management, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Alpine Global Management, LLC reported a position in IMMUNITYBIO INC (IBRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q2)
Avg. % of fund
0.01%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 22,753 +10,019 +78.7% 0.01% $56K $2.46
2024 Q2 REDUCED 12,734 -2,071 -14.0% 0.01% $80K $6.32
2021 Q4 INITIATED 14,805 — — 0.01% $90K $6.08
% of Fund (quarterly)    IBRX price (monthly, adj. close)

Other funds also holding IBRX

As of 2025 Q4 — sorted by position size

Kercheville Advisors, LLC 3Y 1.12% Winning Points Advisors, LLC 3Y 0.54% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.23% Accurate Wealth Management, LLC 3Y 0.17% Virtus Investment Advisers, LLC 3Y 7Y 0.16% Clearwater Capital Advisors, LLC 3Y 7Y 0.14% SHEETS SMITH WEALTH MANAGEMENT 3Y 7Y 0.14% AlphaCore Capital LLC 3Y 0.13% ALLEN HOLDING INC /NY 3Y 7Y 0.13% COLLECTIVE FAMILY OFFICE LLC 3Y 0.07%
← Back to Alpine Global Management, LLC Holdings